Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire made its biggest ever acquisition yet in January 2015 with a $5.2 billion deal for US biotechnology company NPS Pharmaceuticals. The move came a few months after the group's sale to rival AbbVie collapsed.
Financial Data
-
31st Dec 18 Source: CRO
- €13.7 billion turnover
-
€2.4 billion
profit - 22,000 employees
-
31st Dec 17 Source: CRO
- €12.4 billion turnover
-
€3.5 billion
profit - 22,000 employees
- 10 more years available »
Ranking
By Turnover
(€13.7 billion)- 11th in Top Companies
- 2nd in Pharma
By Employees
(22,000)- 7th in Top Companies
- 1st in Pharma
-
- 22,000
- €13.7 billion
Employees
- Flemming Ornskov CEO/Managing Director
Latest News
- 1:24pm Czech court says Skoda, VW owners qualify for €20m compensation
- 12:47pm Brexit: Global firms postponing transfer of capital to EU from UK
- 10:49am Renault-Nissan alliance crumbles with Carlos Ghosn gone
- 10:06am High street hit as consumer spending dips in May
- 10:06am Shopping streets hit as consumer spending dips in May